Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lansoprazole in CAD Patients Undergoing PCI
NCT05820048Phase 4Unknown
- Sponsor
- Daejeon St. Mary's Hospital
- Start
- May 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of lansoprazole in gastrointestinal bleeding, sponsored by Daejeon St. Mary's Hospital. Status: unknown.
02
Drugs
lansoprazole
03
Conditions
gastrointestinal bleeding
Beyond the preview
Go deeper on NCT05820048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05820048.